ABIVAX Société Anonyme (EPA:ABVX)
70.30
+0.20 (0.29%)
Sep 26, 2025, 5:38 PM CET
ABIVAX Société Anonyme Revenue
ABIVAX Société Anonyme had revenue of 1.05M EUR in the quarter ending June 30, 2025, a decrease of -81.34%. This brings the company's revenue in the last twelve months to 6.02M, down -33.90% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.
Revenue (ttm)
6.02M
Revenue Growth
-33.90%
P/S Ratio
882.09
Revenue / Employee
87.29K
Employees
69
Market Cap
5.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.79M | 6.22M | 135.94% |
Dec 31, 2023 | 4.57M | 69.00K | 1.53% |
Dec 31, 2022 | 4.51M | 302.00K | 7.19% |
Dec 31, 2021 | 4.20M | 4.19M | 29,921.43% |
Dec 31, 2020 | 14.00K | 21.00K | -300.00% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
Virbac | 1.43B |
emeis Société anonyme | 5.64B |
ABIVAX Société Anonyme News
- 3 days ago - Abivax (ABVX): JMP Securities Raises Price Target to $114 | ABVX Stock News - GuruFocus
- 5 days ago - Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting - GlobeNewsWire
- 10 days ago - New Option Listings Announced for Abivax (ABVX) - GuruFocus
- 16 days ago - Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - GlobeNewsWire
- 19 days ago - BTIG Reiterates Buy Rating on Abivax (ABVX) with $112 Price Target | ABVX Stock News - GuruFocus
- 20 days ago - Abivax SA (ABVX) Reports First Half 2025 Financial Results | ABVX stock news - GuruFocus
- 20 days ago - Abivax Presents First Half 2025 Financial Results - GlobeNewsWire
- 23 days ago - Abivax (ABVX) Gains on Takeover Speculation - GuruFocus